Impact of Growth Hormone on Cystatin C.

Nephron Extra Pub Date : 2013-11-20 eCollection Date: 2013-01-01 DOI:10.1159/000356464
Lisa Sze, René L Bernays, Cornelia Zwimpfer, Peter Wiesli, Michael Brändle, Christoph Schmid
{"title":"Impact of Growth Hormone on Cystatin C.","authors":"Lisa Sze,&nbsp;René L Bernays,&nbsp;Cornelia Zwimpfer,&nbsp;Peter Wiesli,&nbsp;Michael Brändle,&nbsp;Christoph Schmid","doi":"10.1159/000356464","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Cystatin C (CysC) is an alternative marker to creatinine for estimation of the glomerular filtration rate (GFR). Hormones such as thyroid hormones and glucocorticoids are known to have an impact on CysC. In this study, we examined the effect of growth hormone (GH) on CysC in patients with acromegaly undergoing transsphenoidal surgery.</p><p><strong>Methods: </strong>Creatinine, CysC, GH and insulin-like growth factor-1 (IGF-1) were determined in 24 patients with acromegaly before and following transsphenoidal surgery. Estimated GFR was calculated using the Chronic Kidney Disease Epidemiology Collaboration formula.</p><p><strong>Results: </strong>In all patients, surgical debulking resulted in decreased clinical disease activity and declining GH/IGF-1 levels. Postoperatively, biochemical cure was documented in 20 out of 24 patients. Creatinine levels (mean ± SEM) increased from 72 ± 3 to 80 ± 3 µmol/l (p = 0.0004) and concurrently, estimated GFR decreased from 99 ± 3 to 91 ± 3 ml/min (p = 0.0008). In contrast to creatinine, CysC levels decreased from 0.72 ± 0.02 to 0.68 ± 0.02 mg/l (p = 0.0008).</p><p><strong>Conclusions: </strong>Our study provides strong evidence for discordant effects of GH on creatinine and CysC in patients with acromegaly undergoing transsphenoidal surgery, thus identifying another hormone that influences CysC independent of renal function.</p>","PeriodicalId":56356,"journal":{"name":"Nephron Extra","volume":" ","pages":"118-124"},"PeriodicalIF":0.0000,"publicationDate":"2013-11-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1159/000356464","citationCount":"12","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Nephron Extra","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1159/000356464","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2013/1/1 0:00:00","PubModel":"eCollection","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 12

Abstract

Background: Cystatin C (CysC) is an alternative marker to creatinine for estimation of the glomerular filtration rate (GFR). Hormones such as thyroid hormones and glucocorticoids are known to have an impact on CysC. In this study, we examined the effect of growth hormone (GH) on CysC in patients with acromegaly undergoing transsphenoidal surgery.

Methods: Creatinine, CysC, GH and insulin-like growth factor-1 (IGF-1) were determined in 24 patients with acromegaly before and following transsphenoidal surgery. Estimated GFR was calculated using the Chronic Kidney Disease Epidemiology Collaboration formula.

Results: In all patients, surgical debulking resulted in decreased clinical disease activity and declining GH/IGF-1 levels. Postoperatively, biochemical cure was documented in 20 out of 24 patients. Creatinine levels (mean ± SEM) increased from 72 ± 3 to 80 ± 3 µmol/l (p = 0.0004) and concurrently, estimated GFR decreased from 99 ± 3 to 91 ± 3 ml/min (p = 0.0008). In contrast to creatinine, CysC levels decreased from 0.72 ± 0.02 to 0.68 ± 0.02 mg/l (p = 0.0008).

Conclusions: Our study provides strong evidence for discordant effects of GH on creatinine and CysC in patients with acromegaly undergoing transsphenoidal surgery, thus identifying another hormone that influences CysC independent of renal function.

Abstract Image

生长激素对胱抑素C的影响。
背景:胱抑素C (CysC)是评估肾小球滤过率(GFR)的替代指标,可替代肌酐。众所周知,甲状腺激素和糖皮质激素等激素对CysC有影响。在这项研究中,我们研究了生长激素(GH)对经蝶窦手术的肢端肥大症患者CysC的影响。方法:测定24例肢端肥大症患者经蝶窦手术前后的肌酐、CysC、GH和胰岛素样生长因子-1 (IGF-1)水平。估计GFR使用慢性肾脏疾病流行病学协作公式计算。结果:在所有患者中,手术减体积导致临床疾病活动性降低和GH/IGF-1水平下降。术后24例患者中有20例生化治愈。肌酐水平(平均±SEM)从72±3µmol/l增加到80±3µmol/l (p = 0.0004),同时,估计GFR从99±3下降到91±3 ml/min (p = 0.0008)。与肌酐相比,CysC水平从0.72±0.02 mg/l降至0.68±0.02 mg/l (p = 0.0008)。结论:我们的研究提供了强有力的证据,证明GH对经蝶窦手术肢端肥大症患者肌酐和CysC的影响不一致,从而确定了另一种独立于肾功能影响CysC的激素。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
审稿时长
12 weeks
期刊介绍: An open-access subjournal to Nephron. ''Nephron EXTRA'' publishes additional high-quality articles that cannot be published in the main journal ''Nephron'' due to space limitations.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信